Phase 1 Chronic Hepatitis Clinical Trials

36 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 120 of 36 trials

Recruiting
Phase 1Phase 2

Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus

Chronic Hepatitis Delta
Gilead Sciences200 enrolled19 locationsNCT07096193
Recruiting
Phase 1Phase 2

TherVacB - A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate

Chronic Hepatitis B
Michael Hoelscher81 enrolled6 locationsNCT06513286
Recruiting
Phase 1

A Phase I Clinical Study of AHB - 171 in Healthy Participants(HP) and Chronic Hepatitis B (CHB) Participants

Chronic Hepatitis B Infection
Ausper Biopharma Co., Ltd.110 enrolled1 locationNCT07511218
Recruiting
Phase 1

A Trial to Evaluate the Efficacy and Safety of WGc0201 in Patients With Chronic Hepatitis B Virus Infection

Chronic Hepatitis B Virus (Hbv)
Jiyan Liu9 enrolled1 locationNCT07051187
Recruiting
Phase 1

A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis B

Chronic Hepatitis B Virus Infection
IntegerBio90 enrolled1 locationNCT07389044
Recruiting
Phase 1

Single Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Participants With Renal Impairment and in Healthy Participants With Normal Renal Function

Chronic Hepatitis B Infection
Aligos Therapeutics30 enrolled2 locationsNCT07342881
Recruiting
Phase 1

Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B

Chronic Hepatitis BHBVChronic Hep B+1 more
Tune Therapeutics, Inc.36 enrolled3 locationsNCT06671093
Recruiting
Phase 1

SA1211 Injection Phase 1 Study

Chronic Hepatitis B
Suzhou Siran Biotechnology Co.,Ltd.80 enrolled1 locationNCT07275918
Recruiting
Phase 1

TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B

Hepatitis BChronic Hepatitis B
University of Maryland, Baltimore10 enrolled1 locationNCT04843852
Recruiting
Phase 1

A Study of SN2001 Dose, Safety & Immunogenicity in Healthy Adults

Chronic Hepatitis B Infection
Chimivac INC36 enrolled1 locationNCT07059403
Recruiting
Phase 1

HBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic Hepatitis B Patients

Chronic Hepatitis B
Changhai Hospital19 enrolled1 locationNCT06885710
Recruiting
Phase 1

A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate

Chronic Hepatitis B
Universitätsklinikum Hamburg-Eppendorf24 enrolled2 locationsNCT05727267
Not Yet Recruiting
Phase 1

A study to evaluate the safety, tolerability, pharmacokinetics and antiviral activity of BJT-678 in subjects with chronic Hepatitis B Infection, including subjects with Chronic Hepatitis D infection

Chronic Hepatitis D InfectionChronic Hepatitis B Infection
Bluejay Therapeutics, Inc50 enrolled3 locationsACTRN12625000281493
Not Yet Recruiting
Phase 1

Safety and Tolerability of CLB-4000 in Subjects with Chronic Hepatitis B: Randomised cohort

Chronic Hepatitis B
ClearB Therapeutics, Inc.8 enrolled1 locationACTRN12625000250437
Not Yet Recruiting
Phase 1

Safety and Tolerability of CLB-4000 in Subjects with Chronic Hepatitis B: non-randomised cohorts

Chronic Hepatitis B
ClearB Therapeutics, Inc.17 enrolled1 locationACTRN12625000204448
Not Yet Recruiting
Phase 1

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Cavrotolimod in Subjects with Chronic Hepatitis B Infection

Chronic Hepatitis B Infection
Bluejay Therapeutics, Inc60 enrolled6 locationsACTRN12625000142437
Recruiting
Phase 1Phase 2

From Fungus to Virus, Investigating the Safety and Efficacy of Terbinafine in Chronic Hepatitis B Patients

Chronic Hepatitis B
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)36 enrolled1 locationNCT06295328
Not Yet Recruiting
Phase 1

A study to evaluate the safety, tolerability, pharmacokinetics and antiviral activity of BJT-678 in Healthy volunteers

Chronic Hepatitis D InfectionChronic Hepatitis B Infection
Bluejay Therapeutics, Inc.80 enrolled1 locationACTRN12624001003561
Not Yet Recruiting
Phase 1

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Cavrotolimod in Subjects with Chronic Hepatitis B Infection

Chronic Hepatitis B Infection
Bluejay Therapeutics, Inc80 enrolled6 locationsACTRN12624000809538
Recruiting
Phase 1

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Cavrotolimod in Subjects with Chronic Hepatitis B Infection

Chronic Hepatitis B Infection
Bluejay Therapeutics, Inc40 enrolled6 locationsACTRN12624000808549